Y-mAbs Therapeutics - Stock Price History | YMAB
Historical daily share price chart and data for Y-mAbs Therapeutics since 2021 adjusted for splits. The latest closing stock price for Y-mAbs Therapeutics as of September 24, 2021 is 28.70.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
- The Y-mAbs Therapeutics 52-week high stock price is 55.22, which is 92.4% above the current share price.
- The Y-mAbs Therapeutics 52-week low stock price is 24.77, which is 13.7% below the current share price.
- The average Y-mAbs Therapeutics stock price for the last 52 weeks is 37.86.
|Y-mAbs Therapeutics Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Y-mAbs Therapeutics Inc. is a biopharmaceutical company. It focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The company's product pipeline consists of naxitamab and omburtamab which are in clinical stage. Y-mAbs Therapeutics Inc. is based in NEW YORK, USA.